December 2010

FDA Updates

By

Eribulin, Denosumab, Ipilimumab, and trastuzumab

Hospitals, pharmacists, and physicians across the United States are reporting shortages of critical anticancer drugs, including carboplatin, cisplatin, dacarbazine, fludarabine, and cytarabine.